Chapter 11. Epidemiology and Prevention of Colorectal Cancer

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor2,3,4,5,6,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology7,8,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology6,9,10 and
  4. Yuman Fong MD Professor of Surgery11,12
  1. Paul Moayyedi BSc, MB, ChB, PhD, MPH, FRCP, FRCPC, FACG, AGAF

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch11

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

Moayyedi, P. (2008) Epidemiology and Prevention of Colorectal Cancer, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch11

Editor Information

  1. 2

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 3

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 4

    Cancer Research, UK

  4. 5

    Queen Mary University of London, UK

  5. 6

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 7

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 8

    Southern Arizona VA Health Care System, USA

  8. 9

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 10

    University of Oxford, UK

  10. 11

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 12

    Weill Cornell Medical Center, New York, USA

Author Information

  1. Department of Medicine, McMaster University Medical Centre, Hamilton, ON, Canada

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • colorectal cancer (CRC);
  • colorectal cancer - epidemiology and prevention;
  • non-steroidal anti-inflammatory drugs (NSAIDs);
  • chemoprevention and colorectal cancer incidence reduction;
  • modulating gut flora;
  • colorectal screening as CRC mortality prevention strategy;
  • CRC as global health problem

Summary

This chapter contains sections titled:

  • References